174 related articles for article (PubMed ID: 31609986)
1. Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets.
Stauft CB; Yang C; Coleman JR; Boltz D; Chin C; Kushnir A; Mueller S
PLoS One; 2019; 14(10):e0223784. PubMed ID: 31609986
[TBL] [Abstract][Full Text] [Related]
2. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
[TBL] [Abstract][Full Text] [Related]
3. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
[TBL] [Abstract][Full Text] [Related]
4. A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.
Min JY; Vogel L; Matsuoka Y; Lu B; Swayne D; Jin H; Kemble G; Subbarao K
J Virol; 2010 Nov; 84(22):11950-60. PubMed ID: 20810733
[TBL] [Abstract][Full Text] [Related]
5. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.
Chen Z; Baz M; Lu J; Paskel M; Santos C; Subbarao K; Jin H; Matsuoka Y
J Virol; 2014 Jun; 88(12):7016-23. PubMed ID: 24719414
[TBL] [Abstract][Full Text] [Related]
6. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
[TBL] [Abstract][Full Text] [Related]
7. Cold-adapted X-31 live attenuated 2009 pandemic H1N1 influenza vaccine elicits protective immune responses in mice and ferrets.
Jang YH; Byun YH; Lee DH; Lee KH; Lee YJ; Lee YH; Park JK; Song CS; Seong BL
Vaccine; 2013 Feb; 31(9):1320-7. PubMed ID: 23313655
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.
Rekstin A; Isakova-Sivak I; Petukhova G; Korenkov D; Losev I; Smolonogina T; Tretiak T; Donina S; Shcherbik S; Bousse T; Rudenko L
Biomed Res Int; 2017; 2017():9359276. PubMed ID: 28210631
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets.
Yang P; Duan Y; Wang C; Xing L; Gao X; Tang C; Luo D; Zhao Z; Jia W; Peng D; Liu X; Wang X
Vaccine; 2011 Jan; 29(4):698-705. PubMed ID: 21111782
[TBL] [Abstract][Full Text] [Related]
10. A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations.
Hessel A; Schwendinger M; Fritz D; Coulibaly S; Holzer GW; Sabarth N; Kistner O; Wodal W; Kerschbaum A; Savidis-Dacho H; Crowe BA; Kreil TR; Barrett PN; Falkner FG
PLoS One; 2010 Aug; 5(8):e12217. PubMed ID: 20808939
[TBL] [Abstract][Full Text] [Related]
11. Identification of critical residues in the hemagglutinin and neuraminidase of influenza virus H1N1pdm for vaccine virus replication in embryonated chicken eggs.
Wang W; Lu J; Cotter CR; Wen K; Jin H; Chen Z
J Virol; 2013 Apr; 87(8):4642-9. PubMed ID: 23408613
[TBL] [Abstract][Full Text] [Related]
12. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of pigs with a codon-pair bias de-optimized live attenuated influenza vaccine protects from homologous challenge.
Kaplan BS; Souza CK; Gauger PC; Stauft CB; Robert Coleman J; Mueller S; Vincent AL
Vaccine; 2018 Feb; 36(8):1101-1107. PubMed ID: 29366707
[TBL] [Abstract][Full Text] [Related]
14. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
Front Immunol; 2019; 10():756. PubMed ID: 31105689
[TBL] [Abstract][Full Text] [Related]
15. Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza.
Hossain MJ; Bourgeois M; Quan FS; Lipatov AS; Song JM; Chen LM; Compans RW; York I; Kang SM; Donis RO
Clin Vaccine Immunol; 2011 Dec; 18(12):2010-7. PubMed ID: 22030367
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets.
Pearce MB; Belser JA; Houser KV; Katz JM; Tumpey TM
Vaccine; 2011 Apr; 29(16):2887-94. PubMed ID: 21338676
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
18. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
[TBL] [Abstract][Full Text] [Related]
19. Vaccine-specific antibody secreting cells are a robust early marker of LAIV-induced B-cell response in ferrets.
Cherukuri A; Servat E; Woo J
Vaccine; 2012 Jan; 30(2):237-46. PubMed ID: 22080173
[TBL] [Abstract][Full Text] [Related]
20. A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus.
Smith A; Rodriguez L; El Ghouayel M; Nogales A; Chamberlain JM; Sortino K; Reilly E; Feng C; Topham DJ; Martínez-Sobrido L; Dewhurst S
J Virol; 2020 Jan; 94(4):. PubMed ID: 31748399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
